Investor Relations

Keep up to Date and Stay Informed

Sign up for email alerts to receive company updates including press releases, filings and special announcements straight to your inbox.

Sign me up for:

Latest Financial Results

Q3 2024

Quarter Ended Sep 30, 2024

Latest Annual Report

View Annual Report

Stock Information

Symbol

Nasdaq: BSGM

Price

Change

Volume

52 week Low/High

Day Low/High

Company Overview

BioSig Technologies is a medical device company commercializing a proprietary technology platform designed to improve the $8 billion electrophysiology (EP) marketplace. By 2028, the EP market is expected to reach $16 billion, with an estimated 11.2% CAGR.

Investor Relations

T: (203) 409-5444 x 104
info@biosigtech.com

Transfer Agent

Securities Transfer Corporation
2901 N. Dallas Parkway
Suite 380
Plano, TX 75093
T: (469) 633-0101
F: (469) 633-0088
info@stctransfer.com
www.stctransfer.com